Firstly, we determined the expression levels of five constituents (DUXAP8, DUXAP9, miR-29c-3p, COL1A1 and COL1A2) in 20 pairs of clinical cancer tissues and normal tissues of renal cell carcinoma. This evidence concerns the gene COL1A2 and renal cell carcinoma.